Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine - European Medical Journal

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Oncology

Prof. Solange Peters (Chair), Dr Anne-Marie Baird, Prof. Reinhard B├╝ttner, and Dr Noemi Reguart, will discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges associated with this practice.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now